

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.05707621 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.05707621 |
| 3 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.70596126 |
| 4 | negative regulation of complement activation (GO:0045916) | 4.64620084 |
| 5 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.63709397 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.61172723 |
| 7 | protein maturation by protein folding (GO:0022417) | 4.59928869 |
| 8 | positive regulation of nuclease activity (GO:0032075) | 4.56369551 |
| 9 | negative regulation of protein activation cascade (GO:2000258) | 4.44558397 |
| 10 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.34506640 |
| 11 | sequestering of metal ion (GO:0051238) | 4.27201263 |
| 12 | regulation of nuclease activity (GO:0032069) | 4.21996100 |
| 13 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.15087676 |
| 14 | COPII vesicle coating (GO:0048208) | 4.10948403 |
| 15 | hypotonic response (GO:0006971) | 4.10004644 |
| 16 | negative regulation of humoral immune response (GO:0002921) | 4.01281704 |
| 17 | cellular response to unfolded protein (GO:0034620) | 3.96902192 |
| 18 | vesicle coating (GO:0006901) | 3.86938018 |
| 19 | protein retention in ER lumen (GO:0006621) | 3.86158250 |
| 20 | ER-nucleus signaling pathway (GO:0006984) | 3.78980610 |
| 21 | protein localization to endosome (GO:0036010) | 3.73200718 |
| 22 | cellular response to topologically incorrect protein (GO:0035967) | 3.71230382 |
| 23 | embryonic process involved in female pregnancy (GO:0060136) | 3.68920859 |
| 24 | definitive hemopoiesis (GO:0060216) | 3.47731377 |
| 25 | cellular response to vitamin D (GO:0071305) | 3.35780806 |
| 26 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.28960183 |
| 27 | cellular response to vitamin (GO:0071295) | 3.27657441 |
| 28 | hepatocyte apoptotic process (GO:0097284) | 3.24094878 |
| 29 | response to endoplasmic reticulum stress (GO:0034976) | 3.17989634 |
| 30 | response to unfolded protein (GO:0006986) | 3.14298887 |
| 31 | regulation of complement activation (GO:0030449) | 3.11406744 |
| 32 | positive regulation of histone deacetylation (GO:0031065) | 3.11285709 |
| 33 | regulation of translational termination (GO:0006449) | 3.11034767 |
| 34 | negative regulation of fatty acid transport (GO:2000192) | 3.08810835 |
| 35 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.08781241 |
| 36 | hepatocyte differentiation (GO:0070365) | 3.07962731 |
| 37 | * histone-serine phosphorylation (GO:0035404) | 3.06963137 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.04721544 |
| 39 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.03980751 |
| 40 | Golgi organization (GO:0007030) | 3.02455925 |
| 41 | cell adhesion mediated by integrin (GO:0033627) | 3.01687061 |
| 42 | low-density lipoprotein particle clearance (GO:0034383) | 3.00107840 |
| 43 | regulation of protein activation cascade (GO:2000257) | 3.00030415 |
| 44 | nuclear pore complex assembly (GO:0051292) | 2.99704643 |
| 45 | protein localization to kinetochore (GO:0034501) | 2.98930580 |
| 46 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.96299987 |
| 47 | nuclear pore organization (GO:0006999) | 2.95955754 |
| 48 | regulation of spindle organization (GO:0090224) | 2.92720018 |
| 49 | response to topologically incorrect protein (GO:0035966) | 2.92640371 |
| 50 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.88588682 |
| 51 | desmosome organization (GO:0002934) | 2.88040408 |
| 52 | localization within membrane (GO:0051668) | 2.85294965 |
| 53 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.83137497 |
| 54 | iron ion import (GO:0097286) | 2.83057759 |
| 55 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.80126834 |
| 56 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.77645073 |
| 57 | membrane budding (GO:0006900) | 2.77486211 |
| 58 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.74887346 |
| 59 | necroptotic process (GO:0070266) | 2.74369468 |
| 60 | regulation of metalloenzyme activity (GO:0048552) | 2.74188800 |
| 61 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.73752616 |
| 62 | type B pancreatic cell development (GO:0003323) | 2.73748973 |
| 63 | peptidyl-lysine dimethylation (GO:0018027) | 2.73582949 |
| 64 | regulation of mitotic spindle organization (GO:0060236) | 2.73030332 |
| 65 | import into cell (GO:0098657) | 2.71386195 |
| 66 | membrane raft organization (GO:0031579) | 2.69053139 |
| 67 | peptidyl-proline hydroxylation (GO:0019511) | 2.67379541 |
| 68 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.66906586 |
| 69 | protein hydroxylation (GO:0018126) | 2.65560940 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64641354 |
| 71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.64641354 |
| 72 | peptidyl-asparagine modification (GO:0018196) | 2.64532101 |
| 73 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.63827800 |
| 74 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.63420850 |
| 75 | nerve growth factor signaling pathway (GO:0038180) | 2.62872084 |
| 76 | mesodermal cell differentiation (GO:0048333) | 2.61241199 |
| 77 | nuclear envelope disassembly (GO:0051081) | 2.61180897 |
| 78 | membrane disassembly (GO:0030397) | 2.61180897 |
| 79 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.60840555 |
| 80 | ER overload response (GO:0006983) | 2.60568771 |
| 81 | apoptotic cell clearance (GO:0043277) | 2.60448181 |
| 82 | cortical actin cytoskeleton organization (GO:0030866) | 2.59963653 |
| 83 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.58169549 |
| 84 | regulation of histone H3-K27 methylation (GO:0061085) | 2.57323743 |
| 85 | skin morphogenesis (GO:0043589) | 2.56661274 |
| 86 | cellular extravasation (GO:0045123) | 2.56474428 |
| 87 | mitotic sister chromatid cohesion (GO:0007064) | 2.56186279 |
| 88 | positive regulation of protein deacetylation (GO:0090312) | 2.56137366 |
| 89 | protein autoprocessing (GO:0016540) | 2.54183653 |
| 90 | growth hormone receptor signaling pathway (GO:0060396) | 2.53644446 |
| 91 | pore complex assembly (GO:0046931) | 2.53126095 |
| 92 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.52643112 |
| 93 | peptide hormone processing (GO:0016486) | 2.52027592 |
| 94 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.51561596 |
| 95 | mitotic nuclear envelope disassembly (GO:0007077) | 2.51365306 |
| 96 | diterpenoid biosynthetic process (GO:0016102) | 2.51233321 |
| 97 | cellular response to arsenic-containing substance (GO:0071243) | 2.51149025 |
| 98 | spindle assembly involved in mitosis (GO:0090307) | 2.51066561 |
| 99 | regulation of necroptotic process (GO:0060544) | 2.49259891 |
| 100 | NLS-bearing protein import into nucleus (GO:0006607) | 2.48833379 |
| 101 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.48481215 |
| 102 | positive regulation of osteoblast proliferation (GO:0033690) | 2.46388415 |
| 103 | early endosome to late endosome transport (GO:0045022) | 2.45896612 |
| 104 | toxin metabolic process (GO:0009404) | 2.45364174 |
| 105 | membrane protein ectodomain proteolysis (GO:0006509) | 2.43885958 |
| 106 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 2.43516412 |
| 107 | response to growth hormone (GO:0060416) | 2.42970434 |
| 108 | collagen fibril organization (GO:0030199) | 2.42894635 |
| 109 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.42828241 |
| 110 | plasma membrane repair (GO:0001778) | 2.42085221 |
| 111 | macroautophagy (GO:0016236) | 2.42031647 |
| 112 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.41725024 |
| 113 | histone H2A monoubiquitination (GO:0035518) | 2.41134246 |
| 114 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.40921913 |
| 115 | nuclear envelope organization (GO:0006998) | 2.40167786 |
| 116 | corticosteroid receptor signaling pathway (GO:0031958) | 2.39748092 |
| 117 | regulation of transforming growth factor beta production (GO:0071634) | 2.39493196 |
| 118 | sister chromatid segregation (GO:0000819) | 2.38592531 |
| 119 | IMP metabolic process (GO:0046040) | 2.38420018 |
| 120 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.38181643 |
| 121 | response to lipoprotein particle (GO:0055094) | 2.37920796 |
| 122 | cytokinetic process (GO:0032506) | 2.37134830 |
| 123 | negative regulation of anoikis (GO:2000811) | 2.35529270 |
| 124 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.34562381 |
| 125 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34075168 |
| 126 | protein N-linked glycosylation (GO:0006487) | 2.32926442 |
| 127 | regulation of anoikis (GO:2000209) | 2.32624708 |
| 128 | glandular epithelial cell development (GO:0002068) | 2.32602264 |
| 129 | purine nucleotide salvage (GO:0032261) | 2.32467130 |
| 130 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.31881134 |
| 131 | negative regulation of bone resorption (GO:0045779) | 2.31337182 |
| 132 | positive regulation of receptor recycling (GO:0001921) | 2.31206092 |
| 133 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.31190231 |
| 134 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.31050852 |
| 135 | IMP biosynthetic process (GO:0006188) | 2.30981910 |
| 136 | cellular response to growth hormone stimulus (GO:0071378) | 2.30709792 |
| 137 | endocrine pancreas development (GO:0031018) | 2.30114169 |
| 138 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.29695663 |
| 139 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.29319890 |
| 140 | 4-hydroxyproline metabolic process (GO:0019471) | 2.29253439 |
| 141 | protein targeting to lysosome (GO:0006622) | 2.29004266 |
| 142 | establishment of protein localization to vacuole (GO:0072666) | 2.29004266 |
| 143 | protein targeting to vacuole (GO:0006623) | 2.29004266 |
| 144 | protein localization to chromosome, centromeric region (GO:0071459) | 2.28467732 |
| 145 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.28155927 |
| 146 | positive regulation of chromosome segregation (GO:0051984) | 2.28154979 |
| 147 | pericardium development (GO:0060039) | 2.27367996 |
| 148 | negative regulation of fibrinolysis (GO:0051918) | 2.22904327 |
| 149 | positive regulation of granulocyte differentiation (GO:0030854) | 2.22523803 |
| 150 | regulation of RNA export from nucleus (GO:0046831) | 2.22514834 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.22179415 |
| 152 | interkinetic nuclear migration (GO:0022027) | 2.21761882 |
| 153 | urea cycle (GO:0000050) | 2.20523195 |
| 154 | response to laminar fluid shear stress (GO:0034616) | 2.19304148 |
| 155 | cell-substrate junction assembly (GO:0007044) | 2.17992743 |
| 156 | regulation of integrin activation (GO:0033623) | 2.16706186 |
| 157 | phospholipid translocation (GO:0045332) | 2.15540250 |
| 158 | lipid translocation (GO:0034204) | 2.15540250 |
| 159 | urea metabolic process (GO:0019627) | 2.15351735 |
| 160 | detection of molecule of bacterial origin (GO:0032490) | 2.15076264 |
| 161 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.14884108 |
| 162 | mannose metabolic process (GO:0006013) | 2.14383891 |
| 163 | positive regulation of hemostasis (GO:1900048) | 2.14367986 |
| 164 | positive regulation of blood coagulation (GO:0030194) | 2.14367986 |
| 165 | midgut development (GO:0007494) | 2.11002773 |
| 166 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.10193773 |
| 167 | actin filament depolymerization (GO:0030042) | 2.08006483 |
| 168 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.06185131 |
| 169 | programmed necrotic cell death (GO:0097300) | 2.05624591 |
| 170 | positive regulation of coagulation (GO:0050820) | 2.03821398 |
| 171 | thrombin receptor signaling pathway (GO:0070493) | 2.03200943 |
| 172 | necrotic cell death (GO:0070265) | 2.02833450 |
| 173 | positive regulation of macrophage differentiation (GO:0045651) | 2.02668543 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.01625286 |
| 175 | establishment of endothelial barrier (GO:0061028) | 2.01229993 |
| 176 | regulation of protein localization to plasma membrane (GO:1903076) | 2.01142426 |
| 177 | Golgi to endosome transport (GO:0006895) | 2.00212601 |
| 178 | response to interleukin-15 (GO:0070672) | 1.99053193 |
| 179 | negative regulation of cell killing (GO:0031342) | 1.99021864 |
| 180 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 1.99021864 |
| 181 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.98650940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.13002446 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.36920164 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.83978734 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.58936065 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.53325990 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.02130085 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.66823124 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.58814200 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33886962 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.30281530 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.30184265 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.19926095 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14949577 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.13177930 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12889012 |
| 16 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.10004546 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.04522782 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01866847 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.98862697 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.98496198 |
| 21 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.94680668 |
| 22 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90294630 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.80477411 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.79239949 |
| 25 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78582851 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77148895 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.76142753 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75051210 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.71186545 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.70814545 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67143261 |
| 32 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.66176583 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63826022 |
| 34 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60959557 |
| 35 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60959557 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59998000 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59426385 |
| 38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57456452 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56642340 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56157168 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56008324 |
| 42 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.55214860 |
| 43 | ATF3_27146783_Chip-Seq_COLON_Human | 1.53940728 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51713189 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.51259688 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.50676940 |
| 47 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.48265869 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46596039 |
| 49 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.45851047 |
| 50 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.45800005 |
| 51 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45191123 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.44379601 |
| 53 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44218017 |
| 54 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42331728 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42328540 |
| 56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41812935 |
| 57 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.40369831 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.40279526 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.39555090 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39221018 |
| 61 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39050294 |
| 62 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38782369 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38712219 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37888043 |
| 65 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35848291 |
| 66 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35846596 |
| 67 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.35409776 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34548023 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34548023 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34353187 |
| 71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33941146 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33903543 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33396163 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33219004 |
| 75 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.33137533 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33026699 |
| 77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31934595 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 1.30790485 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30372563 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30324291 |
| 81 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.30230460 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29735967 |
| 83 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.29639565 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29262708 |
| 85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.28769659 |
| 86 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28083986 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27707035 |
| 88 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26358576 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26130420 |
| 90 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24922739 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23822917 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23722926 |
| 93 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23609472 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23032035 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22801682 |
| 96 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.21528762 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19962841 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19772190 |
| 99 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17694977 |
| 100 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.17170942 |
| 101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.16665563 |
| 102 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15772067 |
| 103 | MAF_26560356_Chip-Seq_TH1_Human | 1.15293971 |
| 104 | MYB_26560356_Chip-Seq_TH1_Human | 1.14902907 |
| 105 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14577710 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14333836 |
| 107 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14329759 |
| 108 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.14260362 |
| 109 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12202955 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11813658 |
| 111 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.11286665 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11246664 |
| 113 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10905088 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10652237 |
| 115 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.10550105 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09610875 |
| 117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08993132 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08424400 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07918380 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07724916 |
| 121 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07378385 |
| 122 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06396100 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06189947 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06128449 |
| 125 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.05762965 |
| 126 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05625698 |
| 127 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05199932 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05192841 |
| 129 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04941849 |
| 130 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.04896198 |
| 131 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04886921 |
| 132 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04859236 |
| 133 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04514856 |
| 134 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04093940 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03493038 |
| 136 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03166604 |
| 137 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03137558 |
| 138 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02721556 |
| 139 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.02106629 |
| 140 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01995429 |
| 141 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01677610 |
| 142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01634857 |
| 143 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01367125 |
| 144 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01023299 |
| 145 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00999417 |
| 146 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00935548 |
| 147 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00711557 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00526422 |
| 149 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00421848 |
| 150 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99619918 |
| 151 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.99515303 |
| 152 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98837708 |
| 153 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97507863 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97196474 |
| 155 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95334215 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.69761947 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.58617689 |
| 3 | MP0000013_abnormal_adipose_tissue | 3.07739350 |
| 4 | MP0002009_preneoplasia | 3.01538016 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.98499553 |
| 6 | MP0006054_spinal_hemorrhage | 2.95093496 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.83220592 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.48451517 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.41443384 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.25468418 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.23670648 |
| 12 | MP0003566_abnormal_cell_adhesion | 2.20856983 |
| 13 | MP0005275_abnormal_skin_tensile | 2.11123688 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.07122197 |
| 15 | MP0010307_abnormal_tumor_latency | 2.05876953 |
| 16 | MP0003279_aneurysm | 2.00230401 |
| 17 | MP0000003_abnormal_adipose_tissue | 1.94245988 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.92805409 |
| 19 | MP0002909_abnormal_adrenal_gland | 1.92299929 |
| 20 | MP0005076_abnormal_cell_differentiation | 1.92177051 |
| 21 | MP0000569_abnormal_digit_pigmentation | 1.83085435 |
| 22 | MP0003724_increased_susceptibility_to | 1.78202445 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.72251012 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.65887554 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.64085246 |
| 26 | MP0003091_abnormal_cell_migration | 1.61589461 |
| 27 | MP0003828_pulmonary_edema | 1.61404670 |
| 28 | MP0001299_abnormal_eye_distance/ | 1.59856455 |
| 29 | MP0003123_paternal_imprinting | 1.57016203 |
| 30 | MP0001944_abnormal_pancreas_morphology | 1.52512252 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.49693572 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.47204067 |
| 33 | MP0005023_abnormal_wound_healing | 1.46407028 |
| 34 | MP0004272_abnormal_basement_membrane | 1.45707525 |
| 35 | MP0002693_abnormal_pancreas_physiology | 1.42920877 |
| 36 | MP0002896_abnormal_bone_mineralization | 1.41514926 |
| 37 | MP0004264_abnormal_extraembryonic_tissu | 1.39908106 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.39617079 |
| 39 | MP0003283_abnormal_digestive_organ | 1.39230237 |
| 40 | * MP0003656_abnormal_erythrocyte_physiolo | 1.38695243 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.38611621 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.38277422 |
| 43 | MP0003252_abnormal_bile_duct | 1.37374997 |
| 44 | MP0008057_abnormal_DNA_replication | 1.36560481 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.36102008 |
| 46 | MP0000733_abnormal_muscle_development | 1.29591084 |
| 47 | MP0005164_abnormal_response_to | 1.29397583 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.29081233 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.28680085 |
| 50 | MP0001851_eye_inflammation | 1.28139911 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.26317632 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.25018124 |
| 53 | MP0001730_embryonic_growth_arrest | 1.22428026 |
| 54 | MP0001958_emphysema | 1.22373204 |
| 55 | MP0004947_skin_inflammation | 1.21975911 |
| 56 | MP0003303_peritoneal_inflammation | 1.17368428 |
| 57 | MP0002396_abnormal_hematopoietic_system | 1.16100711 |
| 58 | MP0003868_abnormal_feces_composition | 1.14779881 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.14288982 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.14186032 |
| 61 | MP0002060_abnormal_skin_morphology | 1.09077474 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.08516332 |
| 63 | * MP0004808_abnormal_hematopoietic_stem | 1.07344070 |
| 64 | MP0005408_hypopigmentation | 1.07149048 |
| 65 | MP0003045_fibrosis | 1.06802753 |
| 66 | MP0005360_urolithiasis | 1.04515443 |
| 67 | MP0000767_abnormal_smooth_muscle | 1.03257782 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 1.03143889 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.02909892 |
| 70 | MP0004883_abnormal_blood_vessel | 1.02240969 |
| 71 | MP0004233_abnormal_muscle_weight | 1.00766109 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.00351644 |
| 73 | MP0005503_abnormal_tendon_morphology | 0.99289422 |
| 74 | MP0009384_cardiac_valve_regurgitation | 0.98714764 |
| 75 | MP0001915_intracranial_hemorrhage | 0.98393132 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.98365900 |
| 77 | MP0001873_stomach_inflammation | 0.97491448 |
| 78 | MP0000858_altered_metastatic_potential | 0.96984425 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.95111408 |
| 80 | MP0009697_abnormal_copulation | 0.94654303 |
| 81 | MP0000350_abnormal_cell_proliferation | 0.94305262 |
| 82 | MP0005621_abnormal_cell_physiology | 0.93831843 |
| 83 | MP0001661_extended_life_span | 0.93133336 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.93058940 |
| 85 | MP0003436_decreased_susceptibility_to | 0.92089058 |
| 86 | MP0001849_ear_inflammation | 0.91681033 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.91588607 |
| 88 | MP0000249_abnormal_blood_vessel | 0.91307719 |
| 89 | MP0000383_abnormal_hair_follicle | 0.90231375 |
| 90 | MP0002086_abnormal_extraembryonic_tissu | 0.89872091 |
| 91 | MP0001243_abnormal_dermal_layer | 0.87345154 |
| 92 | MP0000428_abnormal_craniofacial_morphol | 0.86605460 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.86043892 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.85910378 |
| 95 | MP0005365_abnormal_bile_salt | 0.85888953 |
| 96 | MP0002080_prenatal_lethality | 0.84278215 |
| 97 | MP0005379_endocrine/exocrine_gland_phen | 0.83978204 |
| 98 | MP0005257_abnormal_intraocular_pressure | 0.83557879 |
| 99 | MP0001545_abnormal_hematopoietic_system | 0.83303070 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.83303070 |
| 101 | MP0004197_abnormal_fetal_growth/weight/ | 0.82828222 |
| 102 | MP0005409_darkened_coat_color | 0.82134143 |
| 103 | MP0000609_abnormal_liver_physiology | 0.81708090 |
| 104 | MP0001697_abnormal_embryo_size | 0.81664753 |
| 105 | MP0005165_increased_susceptibility_to | 0.81457717 |
| 106 | MP0002006_tumorigenesis | 0.80605686 |
| 107 | MP0009333_abnormal_splenocyte_physiolog | 0.80483728 |
| 108 | MP0002269_muscular_atrophy | 0.79467253 |
| 109 | MP0000358_abnormal_cell_content/ | 0.79382118 |
| 110 | MP0003984_embryonic_growth_retardation | 0.79368186 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.78579469 |
| 112 | MP0004084_abnormal_cardiac_muscle | 0.78315249 |
| 113 | MP0002088_abnormal_embryonic_growth/wei | 0.77953571 |
| 114 | MP0000627_abnormal_mammary_gland | 0.77614713 |
| 115 | MP0002933_joint_inflammation | 0.77512983 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.76644385 |
| 117 | MP0004484_altered_response_of | 0.76593668 |
| 118 | MP0009703_decreased_birth_body | 0.76399937 |
| 119 | MP0000747_muscle_weakness | 0.75043411 |
| 120 | MP0008260_abnormal_autophagy | 0.74788989 |
| 121 | MP0005451_abnormal_body_composition | 0.74265919 |
| 122 | MP0002971_abnormal_brown_adipose | 0.73946651 |
| 123 | MP0002136_abnormal_kidney_physiology | 0.73909901 |
| 124 | MP0008961_abnormal_basal_metabolism | 0.73664189 |
| 125 | MP0005384_cellular_phenotype | 0.73606114 |
| 126 | MP0003111_abnormal_nucleus_morphology | 0.73417488 |
| 127 | MP0002405_respiratory_system_inflammati | 0.72823771 |
| 128 | MP0008004_abnormal_stomach_pH | 0.71974770 |
| 129 | MP0006138_congestive_heart_failure | 0.71885067 |
| 130 | MP0003077_abnormal_cell_cycle | 0.71763440 |
| 131 | MP0003448_altered_tumor_morphology | 0.71460331 |
| 132 | MP0001672_abnormal_embryogenesis/_devel | 0.71148458 |
| 133 | MP0005380_embryogenesis_phenotype | 0.71148458 |
| 134 | MP0001756_abnormal_urination | 0.71055424 |
| 135 | MP0000371_diluted_coat_color | 0.70724674 |
| 136 | MP0002419_abnormal_innate_immunity | 0.70454714 |
| 137 | MP0000749_muscle_degeneration | 0.68966804 |
| 138 | MP0003795_abnormal_bone_structure | 0.68313497 |
| 139 | MP0002128_abnormal_blood_circulation | 0.67826707 |
| 140 | MP0002970_abnormal_white_adipose | 0.67159948 |
| 141 | MP0001191_abnormal_skin_condition | 0.66671674 |
| 142 | MP0008007_abnormal_cellular_replicative | 0.65621362 |
| 143 | MP0009643_abnormal_urine_homeostasis | 0.65575921 |
| 144 | MP0001879_abnormal_lymphatic_vessel | 0.65383644 |
| 145 | MP0002928_abnormal_bile_duct | 0.65370593 |
| 146 | MP0005390_skeleton_phenotype | 0.64670792 |
| 147 | MP0002295_abnormal_pulmonary_circulatio | 0.64594564 |
| 148 | MP0004043_abnormal_pH_regulation | 0.64570671 |
| 149 | MP0002168_other_aberrant_phenotype | 0.64317086 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.63550775 |
| 151 | MP0009115_abnormal_fat_cell | 0.63427801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.38954449 |
| 2 | Cervical subluxation (HP:0003308) | 3.91453950 |
| 3 | Protrusio acetabuli (HP:0003179) | 3.67912182 |
| 4 | Papilledema (HP:0001085) | 3.54602156 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.53146425 |
| 6 | Ankle contracture (HP:0006466) | 3.34233328 |
| 7 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.33817483 |
| 8 | Osteolytic defects of the hand bones (HP:0009699) | 3.33817483 |
| 9 | Thoracolumbar scoliosis (HP:0002944) | 3.24290499 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.02886912 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.97810323 |
| 12 | Cardiovascular calcification (HP:0011915) | 2.97711123 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96350564 |
| 14 | Asymmetry of the thorax (HP:0001555) | 2.92322740 |
| 15 | Increased mean platelet volume (HP:0011877) | 2.85807634 |
| 16 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.84374927 |
| 17 | Aortic aneurysm (HP:0004942) | 2.84297671 |
| 18 | Gingival bleeding (HP:0000225) | 2.83156361 |
| 19 | Mitral stenosis (HP:0001718) | 2.82319055 |
| 20 | Dilatation of the ascending aorta (HP:0005111) | 2.81113438 |
| 21 | Vascular calcification (HP:0004934) | 2.76796693 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.76251252 |
| 23 | Mucopolysacchariduria (HP:0008155) | 2.76251252 |
| 24 | Severe short stature (HP:0003510) | 2.76078660 |
| 25 | Vertebral compression fractures (HP:0002953) | 2.72217730 |
| 26 | Short nail (HP:0001799) | 2.70833046 |
| 27 | Spinal cord lesions (HP:0100561) | 2.67428267 |
| 28 | Syringomyelia (HP:0003396) | 2.67428267 |
| 29 | Abnormal platelet volume (HP:0011876) | 2.66550816 |
| 30 | Hyperglycemia (HP:0003074) | 2.60733461 |
| 31 | Ankyloglossia (HP:0010296) | 2.58894846 |
| 32 | Curly hair (HP:0002212) | 2.57530777 |
| 33 | Broad face (HP:0000283) | 2.52596293 |
| 34 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.50859959 |
| 35 | Menorrhagia (HP:0000132) | 2.50394252 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.50079470 |
| 37 | Shallow orbits (HP:0000586) | 2.47610510 |
| 38 | Scapular winging (HP:0003691) | 2.41588994 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38380044 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.38259028 |
| 41 | Soft skin (HP:0000977) | 2.37855633 |
| 42 | Wormian bones (HP:0002645) | 2.37149890 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.33511344 |
| 44 | Hand muscle atrophy (HP:0009130) | 2.31026834 |
| 45 | Papillary thyroid carcinoma (HP:0002895) | 2.30991277 |
| 46 | Thin bony cortex (HP:0002753) | 2.29848772 |
| 47 | Increased connective tissue (HP:0009025) | 2.29610631 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.28851289 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.27570637 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26934062 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26934062 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26934062 |
| 53 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.26081734 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.25176244 |
| 55 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.23776136 |
| 56 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.23776136 |
| 57 | Abnormal glucose tolerance (HP:0001952) | 2.22587888 |
| 58 | Increased density of long bones (HP:0006392) | 2.22247573 |
| 59 | Myocardial infarction (HP:0001658) | 2.21685231 |
| 60 | Aortic dissection (HP:0002647) | 2.21199789 |
| 61 | Subacute progressive viral hepatitis (HP:0006572) | 2.20490694 |
| 62 | Hypobetalipoproteinemia (HP:0003563) | 2.17594854 |
| 63 | Exostoses (HP:0100777) | 2.15959493 |
| 64 | Aneurysm (HP:0002617) | 2.15838322 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 2.14916961 |
| 66 | Upper limb amyotrophy (HP:0009129) | 2.14916961 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.14468268 |
| 68 | Epistaxis (HP:0000421) | 2.13737167 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11914503 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.10076143 |
| 71 | Hematochezia (HP:0002573) | 2.07633600 |
| 72 | Termporal pattern (HP:0011008) | 2.05539101 |
| 73 | Insidious onset (HP:0003587) | 2.05539101 |
| 74 | Abnormal foot bone ossification (HP:0010675) | 2.03240496 |
| 75 | Eczematoid dermatitis (HP:0000976) | 2.03018084 |
| 76 | Entropion (HP:0000621) | 2.00965014 |
| 77 | Periodontitis (HP:0000704) | 1.99275881 |
| 78 | Hypercortisolism (HP:0001578) | 1.97894393 |
| 79 | Abnormality of the intrinsic pathway (HP:0010989) | 1.97877854 |
| 80 | Thickened calvaria (HP:0002684) | 1.97610692 |
| 81 | Absent frontal sinuses (HP:0002688) | 1.97159518 |
| 82 | Persistence of primary teeth (HP:0006335) | 1.96611789 |
| 83 | Multiple enchondromatosis (HP:0005701) | 1.95847462 |
| 84 | Spinal rigidity (HP:0003306) | 1.95708479 |
| 85 | Fatigue (HP:0012378) | 1.95520593 |
| 86 | Macroorchidism (HP:0000053) | 1.95248046 |
| 87 | Sparse lateral eyebrow (HP:0005338) | 1.95035780 |
| 88 | Glucose intolerance (HP:0000833) | 1.94352903 |
| 89 | Cupped ribs (HP:0000887) | 1.92818463 |
| 90 | Global brain atrophy (HP:0002283) | 1.92339168 |
| 91 | Abnormality of oral frenula (HP:0000190) | 1.91411648 |
| 92 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.89991173 |
| 93 | Mitral valve prolapse (HP:0001634) | 1.88388690 |
| 94 | Vascular tortuosity (HP:0004948) | 1.88358255 |
| 95 | Beaking of vertebral bodies (HP:0004568) | 1.87913864 |
| 96 | Radial bowing (HP:0002986) | 1.87611906 |
| 97 | Relative macrocephaly (HP:0004482) | 1.87367746 |
| 98 | Difficulty climbing stairs (HP:0003551) | 1.87293805 |
| 99 | Abnormality of the acetabulum (HP:0003170) | 1.85990903 |
| 100 | Dislocated radial head (HP:0003083) | 1.85771448 |
| 101 | T lymphocytopenia (HP:0005403) | 1.85613943 |
| 102 | Fair hair (HP:0002286) | 1.84976273 |
| 103 | Polycythemia (HP:0001901) | 1.84389993 |
| 104 | Acute myeloid leukemia (HP:0004808) | 1.84269991 |
| 105 | Deep venous thrombosis (HP:0002625) | 1.84034741 |
| 106 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.83548313 |
| 107 | Genu recurvatum (HP:0002816) | 1.83154020 |
| 108 | Dysmetric saccades (HP:0000641) | 1.82591793 |
| 109 | Enlarged penis (HP:0000040) | 1.82274764 |
| 110 | Platyspondyly (HP:0000926) | 1.81533723 |
| 111 | Orthostatic hypotension (HP:0001278) | 1.81462765 |
| 112 | Abnormality of T cell number (HP:0011839) | 1.81161057 |
| 113 | Volvulus (HP:0002580) | 1.80801734 |
| 114 | Spinal cord compression (HP:0002176) | 1.80693897 |
| 115 | Joint stiffness (HP:0001387) | 1.80239572 |
| 116 | Thyroid carcinoma (HP:0002890) | 1.80121583 |
| 117 | Chronic diarrhea (HP:0002028) | 1.79290623 |
| 118 | Spinal muscular atrophy (HP:0007269) | 1.79261406 |
| 119 | Deep philtrum (HP:0002002) | 1.78522655 |
| 120 | Vertebral hypoplasia (HP:0008417) | 1.78103811 |
| 121 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.78103811 |
| 122 | Peritonitis (HP:0002586) | 1.77794464 |
| 123 | Buphthalmos (HP:0000557) | 1.76023455 |
| 124 | Flat acetabular roof (HP:0003180) | 1.75979183 |
| 125 | Limb-girdle muscle atrophy (HP:0003797) | 1.75225997 |
| 126 | Coarse hair (HP:0002208) | 1.73569010 |
| 127 | Bladder diverticulum (HP:0000015) | 1.73565100 |
| 128 | Ovoid vertebral bodies (HP:0003300) | 1.72900588 |
| 129 | Overgrowth (HP:0001548) | 1.72749307 |
| 130 | Insulin resistance (HP:0000855) | 1.71589400 |
| 131 | Fragile skin (HP:0001030) | 1.71468798 |
| 132 | Arterial tortuosity (HP:0005116) | 1.71434775 |
| 133 | Metaphyseal cupping (HP:0003021) | 1.71250208 |
| 134 | Cutaneous melanoma (HP:0012056) | 1.69166967 |
| 135 | Abnormality of the odontoid process (HP:0003310) | 1.68852104 |
| 136 | Hypoplasia of the odontoid process (HP:0003311) | 1.68825507 |
| 137 | Wrist flexion contracture (HP:0001239) | 1.68725611 |
| 138 | Testicular neoplasm (HP:0010788) | 1.68578668 |
| 139 | Symptomatic seizures (HP:0011145) | 1.68301405 |
| 140 | Missing ribs (HP:0000921) | 1.67996569 |
| 141 | Long toe (HP:0010511) | 1.67764975 |
| 142 | Coxa vara (HP:0002812) | 1.67498853 |
| 143 | Acanthocytosis (HP:0001927) | 1.67468656 |
| 144 | Gingivitis (HP:0000230) | 1.67316777 |
| 145 | Autoimmune hemolytic anemia (HP:0001890) | 1.67265293 |
| 146 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.67236801 |
| 147 | Spondylolisthesis (HP:0003302) | 1.66916698 |
| 148 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66480463 |
| 149 | Atrophic scars (HP:0001075) | 1.65792068 |
| 150 | Arterial thrombosis (HP:0004420) | 1.65670773 |
| 151 | Tetraparesis (HP:0002273) | 1.65177292 |
| 152 | Resting tremor (HP:0002322) | 1.64872976 |
| 153 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64437214 |
| 154 | Striae distensae (HP:0001065) | 1.64269467 |
| 155 | Generalized hypopigmentation of hair (HP:0011358) | 1.64196833 |
| 156 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.63556927 |
| 157 | Abnormality of skull ossification (HP:0002703) | 1.62837749 |
| 158 | Submucous cleft hard palate (HP:0000176) | 1.62737592 |
| 159 | Congenital glaucoma (HP:0001087) | 1.62416236 |
| 160 | Vertebral arch anomaly (HP:0008438) | 1.62130083 |
| 161 | Bowel diverticulosis (HP:0005222) | 1.61761401 |
| 162 | Autoamputation (HP:0001218) | 1.61385690 |
| 163 | Cranial hyperostosis (HP:0004437) | 1.61359533 |
| 164 | Fat malabsorption (HP:0002630) | 1.61151357 |
| 165 | Gastrointestinal infarctions (HP:0005244) | 1.59278446 |
| 166 | Right ventricular cardiomyopathy (HP:0011663) | 1.58993939 |
| 167 | Viral hepatitis (HP:0006562) | 1.58991394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCYL2 | 3.46452850 |
| 2 | TRIB3 | 2.71286518 |
| 3 | FLT3 | 2.64668035 |
| 4 | AKT3 | 2.43979240 |
| 5 | PDGFRA | 2.37184613 |
| 6 | FRK | 2.30908044 |
| 7 | TTN | 2.29697498 |
| 8 | CDK12 | 2.27730207 |
| 9 | TAOK3 | 2.23698968 |
| 10 | LATS1 | 2.15549121 |
| 11 | PKN2 | 2.14669366 |
| 12 | LRRK2 | 2.07487271 |
| 13 | STK10 | 1.98256174 |
| 14 | PASK | 1.91454179 |
| 15 | BUB1 | 1.89975222 |
| 16 | ACVR1B | 1.89582109 |
| 17 | RPS6KA4 | 1.89396302 |
| 18 | MAP3K2 | 1.89182315 |
| 19 | MAP3K14 | 1.87084671 |
| 20 | BMPR2 | 1.75113549 |
| 21 | EPHA3 | 1.73361502 |
| 22 | ERN1 | 1.71061246 |
| 23 | PTK6 | 1.68021153 |
| 24 | TESK1 | 1.67360958 |
| 25 | IRAK1 | 1.60748660 |
| 26 | NEK1 | 1.59839296 |
| 27 | STK3 | 1.53096562 |
| 28 | PTK2 | 1.48171471 |
| 29 | YES1 | 1.46449801 |
| 30 | MET | 1.46319701 |
| 31 | CDK6 | 1.44778526 |
| 32 | WEE1 | 1.37632339 |
| 33 | EPHB1 | 1.36421012 |
| 34 | ERBB3 | 1.33926904 |
| 35 | MYLK | 1.33205754 |
| 36 | NLK | 1.31300931 |
| 37 | NTRK1 | 1.29207190 |
| 38 | EEF2K | 1.27896572 |
| 39 | TRPM7 | 1.26920191 |
| 40 | LIMK1 | 1.24064775 |
| 41 | MAP3K3 | 1.22594497 |
| 42 | IRAK3 | 1.21299543 |
| 43 | INSRR | 1.20912834 |
| 44 | STK39 | 1.16966861 |
| 45 | PIM2 | 1.16289048 |
| 46 | NEK2 | 1.16224560 |
| 47 | MAP3K8 | 1.16151214 |
| 48 | ALK | 1.15674772 |
| 49 | MAP3K6 | 1.15453065 |
| 50 | DDR2 | 1.14591443 |
| 51 | PDK2 | 1.13625878 |
| 52 | EPHA2 | 1.11431596 |
| 53 | PAK2 | 1.11410211 |
| 54 | BRD4 | 1.04909108 |
| 55 | RIPK1 | 1.04241193 |
| 56 | WNK1 | 1.04079121 |
| 57 | HIPK2 | 1.03947900 |
| 58 | CDC7 | 1.03239958 |
| 59 | PAK4 | 1.00598329 |
| 60 | PRPF4B | 0.99894636 |
| 61 | TESK2 | 0.99663516 |
| 62 | NEK9 | 0.98879904 |
| 63 | JAK1 | 0.98665555 |
| 64 | MAPK11 | 0.97846480 |
| 65 | ERBB4 | 0.97486115 |
| 66 | FER | 0.96080310 |
| 67 | JAK3 | 0.93451790 |
| 68 | STK24 | 0.92689176 |
| 69 | ICK | 0.92682564 |
| 70 | IRAK4 | 0.92465556 |
| 71 | MAP2K3 | 0.89328335 |
| 72 | EIF2AK1 | 0.87626809 |
| 73 | MAP3K12 | 0.87486326 |
| 74 | RET | 0.87234619 |
| 75 | FGFR3 | 0.85144181 |
| 76 | BTK | 0.85122790 |
| 77 | MST1R | 0.84775462 |
| 78 | PAK3 | 0.83018510 |
| 79 | PDGFRB | 0.82964161 |
| 80 | STK38 | 0.81650663 |
| 81 | EIF2AK3 | 0.81124645 |
| 82 | MTOR | 0.79959962 |
| 83 | MAP2K1 | 0.79502147 |
| 84 | CSK | 0.78803955 |
| 85 | PTK2B | 0.77356071 |
| 86 | SIK1 | 0.76689204 |
| 87 | NEK6 | 0.76599795 |
| 88 | MST4 | 0.75564043 |
| 89 | KSR2 | 0.73734696 |
| 90 | CAMK1D | 0.73608337 |
| 91 | IRAK2 | 0.73039615 |
| 92 | KDR | 0.70930776 |
| 93 | MARK3 | 0.70885472 |
| 94 | STK38L | 0.69334842 |
| 95 | CAMK1G | 0.68934732 |
| 96 | ITK | 0.68117956 |
| 97 | SGK3 | 0.67458482 |
| 98 | RIPK4 | 0.67437944 |
| 99 | TGFBR2 | 0.65996945 |
| 100 | AURKB | 0.65740618 |
| 101 | RPS6KB2 | 0.65074508 |
| 102 | HCK | 0.61760111 |
| 103 | BMX | 0.61735598 |
| 104 | MAPKAPK3 | 0.61619799 |
| 105 | FGFR1 | 0.61138502 |
| 106 | TGFBR1 | 0.60989863 |
| 107 | GRK6 | 0.59500585 |
| 108 | NUAK1 | 0.59373484 |
| 109 | JAK2 | 0.59110067 |
| 110 | DYRK1B | 0.58955939 |
| 111 | PRKD3 | 0.57770504 |
| 112 | MAP3K7 | 0.56838083 |
| 113 | MOS | 0.56228859 |
| 114 | MAP3K13 | 0.54738877 |
| 115 | SIK3 | 0.54708043 |
| 116 | PBK | 0.54304846 |
| 117 | PRKCH | 0.53766705 |
| 118 | * PRKAA2 | 0.53314756 |
| 119 | PIK3CA | 0.52351782 |
| 120 | PDPK1 | 0.52238157 |
| 121 | PDK1 | 0.50573383 |
| 122 | FGFR4 | 0.50530271 |
| 123 | TBK1 | 0.49434928 |
| 124 | GSK3A | 0.49202112 |
| 125 | KSR1 | 0.48345454 |
| 126 | PRKD1 | 0.48178959 |
| 127 | LMTK2 | 0.47240486 |
| 128 | WNK4 | 0.46016361 |
| 129 | PIM1 | 0.45098712 |
| 130 | CDK4 | 0.42161209 |
| 131 | PRKG2 | 0.40772508 |
| 132 | TSSK6 | 0.38489190 |
| 133 | MAP3K1 | 0.38336046 |
| 134 | MAPK15 | 0.38032610 |
| 135 | ZAP70 | 0.37012987 |
| 136 | PIK3CG | 0.35874549 |
| 137 | TYK2 | 0.35279906 |
| 138 | TEC | 0.33511550 |
| 139 | PAK1 | 0.33252684 |
| 140 | IGF1R | 0.32960787 |
| 141 | CDC42BPA | 0.32657489 |
| 142 | MELK | 0.32590089 |
| 143 | CSNK1A1L | 0.32353924 |
| 144 | TTK | 0.30427578 |
| 145 | PLK3 | 0.30302965 |
| 146 | EGFR | 0.30290623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.19789465 |
| 2 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.98529943 |
| 3 | Protein export_Homo sapiens_hsa03060 | 1.95713492 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 1.89976959 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83897995 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.79523668 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76287957 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.71306372 |
| 9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54068729 |
| 10 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.50718835 |
| 11 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.45044385 |
| 12 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.42391065 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 1.41405600 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.40329988 |
| 15 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40082613 |
| 16 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.37421861 |
| 17 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.34305813 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33217676 |
| 19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30849779 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29893658 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27795814 |
| 22 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26844876 |
| 23 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.25368454 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.22863309 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.21703535 |
| 26 | Thyroid cancer_Homo sapiens_hsa05216 | 1.19682782 |
| 27 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.17203444 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16910628 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16885388 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.16735852 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.15986597 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.15726806 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.15543955 |
| 34 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.14459439 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14217269 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.14127001 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.14098836 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13699433 |
| 39 | Endocytosis_Homo sapiens_hsa04144 | 1.13306610 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11988875 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.11669068 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.11583232 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11124391 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10311399 |
| 45 | Amoebiasis_Homo sapiens_hsa05146 | 1.09840667 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.08142694 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07150858 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04181855 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03932192 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03783139 |
| 51 | * Insulin resistance_Homo sapiens_hsa04931 | 1.01251405 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99900004 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99696821 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99577530 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96354748 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.95120412 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.95020232 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94059045 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93527166 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93360165 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92394761 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91961425 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.91849478 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91525315 |
| 65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89904679 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89649863 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89413005 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88137487 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.86312089 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84673841 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84670519 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84639927 |
| 73 | Influenza A_Homo sapiens_hsa05164 | 0.83376947 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83171325 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83106112 |
| 76 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.83000338 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.79898764 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78844681 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78400307 |
| 80 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78385631 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.76964821 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76687381 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.75991292 |
| 84 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75566626 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75298733 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75247928 |
| 87 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.74808375 |
| 88 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74168397 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73621349 |
| 90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73528463 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73386218 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.73276049 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72384659 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72201286 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71756962 |
| 96 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71047690 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69597213 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69161757 |
| 99 | Measles_Homo sapiens_hsa05162 | 0.69002268 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.68890510 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68515760 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68083961 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68051926 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67828132 |
| 105 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67519721 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65870763 |
| 107 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64834559 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64619897 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64386626 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64291450 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64261678 |
| 112 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63907094 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62271225 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.61501885 |
| 115 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60973607 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59975579 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.59763042 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.59609861 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.59262943 |
| 120 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58921643 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58271357 |
| 122 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57923012 |
| 123 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56845348 |
| 124 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56503753 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56219632 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55947053 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55918342 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55481824 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54951104 |
| 130 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54316202 |
| 131 | Mineral absorption_Homo sapiens_hsa04978 | 0.53891198 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52695854 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.52630756 |
| 134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51651272 |

